Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma

被引：6
|
作者：
Wang, Xiaoli [1 ]
Wu, Jingjing [1 ]
Zhang, Mingzhi [1 ]
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Zhengzhou, Henan, Peoples R China
来源：
HEMATOLOGY | 2019年 / 24卷 / 01期
关键词：
Anaplastic large cell lymphoma; anaplastic lymphoma kinase; treatment; prognosis; PIVOTAL PHASE-II; BRENTUXIMAB VEDOTIN; OPEN-LABEL; ALK; DISEASE; TRANSPLANTATION; MULTICENTER; DOXORUBICIN; ADULTS; ERA;
D O I：
10.1080/16078454.2019.1613290
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Anaplastic lymphoma kinase negative anaplastic large cell lymphoma (ALK- ALCL) is a definite entity in the WHO 2016 Classification that represents 2-3% of non-Hodgkin lymphoma (NHL) and 12% of T-cell NHL cases. ALK- ALCL lacks ALK protein expression, but expresses CD30 and has morphologic features similar to ALK positive anaplastic large cell lymphoma (ALK+ ALCL). Some studies indicate that ALK- ALCL and ALK+ ALCL possess different molecular and genetic characteristics. Besides, ALK- ALCL is worse than ALK+ ALCL in terms of treatment outcome, prognosis, and long-term survival. This review is aimed at summarizing information about ALK- ALCL, especially with respect to the treatment and prognosis.
引用
收藏
页码：440 / 445
页数：6
相关论文
共 50 条
  • [21] A primary retroperitoneal anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor thrombosis
    Li, Jisong
    Tian, Xiaodong
    Wang, Mangju
    Liu, Wei
    Guo, Xiaochao
    Wang, Ke
    Nong, Lin
    Wang, Wei
    Yang, Yinmo
    ONCOTARGETS AND THERAPY, 2018, 11 : 9007 - 9011
  • [22] Primary gastrointestinal anaplastic large cell lymphoma
    Lee, Yi-Ying
    Takata, Katsuyoshi
    Wang, Ren-Ching
    Yang, Sheau-Fang
    Chuang, Shih-Sung
    PATHOLOGY, 2017, 49 (05) : 479 - 485
  • [23] Primary bone anaplastic lymphoma kinase positive anaplastic large-cell lymphoma: A case report and review of the literature
    Zheng, Wei
    Yin, Qiao-Qiao
    Hui, Tian-Chen
    Wu, Wen-Hao
    Wu, Qing-Qing
    Huang, Hai-Jun
    Chen, Mei-Juan
    Yan, Rong
    Huang, Yi-Cheng
    Pan, Hong-Ying
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (14) : 3403 - 3410
  • [24] Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease
    Eyre, Toby A.
    Khan, Dalia
    Hall, Georgina W.
    Collins, Graham P.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (06) : 455 - 468
  • [25] Anaplastic lymphoma kinase-negative anaplastic large cell lymphoma with extranodal involvement of the thigh muscle: A case report
    Emori M.
    Kaya M.
    Takahata S.
    Tobioka H.
    Minaki Y.
    Yamashita T.
    Journal of Medical Case Reports, 8 (1)
  • [26] Anaplastic large cell lymphoma
    Medeiros, L. Jeffrey
    Elenitoba-Johnson, Kojo S. J.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 127 (05) : 707 - 722
  • [27] Anaplastic lymphoma kinase-negative anaplastic large cell lymphoma masquerading as Behcet's disease: A case report and review of literature
    Juan Luo
    Ying-Han Jiang
    Zi Lei
    Ying-Lei Miao
    World Journal of Clinical Cases, 2019, (20) : 3377 - 3383
  • [28] Brentuximab vedotin use in pediatric anaplastic large cell lymphoma
    Agrusa, Jennifer E.
    Egress, Emily R.
    Lowe, Eric J.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [29] FDG PET/CT in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
    Angamuthu, Meivel
    Kaur, Kanwaljeet
    Tripathi, Madhavi
    Meena, Jagdish Prasad
    Seth, Rachna
    Kumar, Rakesh
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (07) : 540 - 541
  • [30] Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma
    Beaven, Anne W.
    Diehl, Louis F.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 550 - 558
12345